Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies

BACKGROUND: Patients with restrictive or hypertrophic cardiomyopathy (RCM/HCM) and congenital heart disease (CHD) do not derive clinical benefit from inotropes and mechanical circulatory support. Concerns were expressed that the new heart allocation system implemented in October 2018 would disadvant...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Chouairi, Fouad, Mullan, Clancy W., Sen, Sounok, Mori, Makoto, Fuery, Michael, Elder, Robert W., Lesse, Joshua, Norton, Kelsey, Clark, Katherine A., Miller, P. Elliott, Mulligan, David, Formica, Richard, Rogers, Joseph G., Jacoby, Daniel, Maulion, Christopher, Anwer, Muhammad, Geirsson, Arnar, Desai, Nihar R., Ahmad, Tariq
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7924739/
https://ncbi.nlm.nih.gov/pubmed/33651802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247789
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires